• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

    2/4/25 9:58:04 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost.

    "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Board," said Todd Stottlemyer, CEO of Acentra Health. "Each brings decades of experience navigating and improving complex healthcare delivery systems across state and federal governments to successfully drive better outcomes in patient care. Their guidance will enhance our strategy to help our clients address their toughest challenges and deliver better health outcomes for the populations they serve."

    About Calder Lynch

    Calder Lynch is a nationally recognized healthcare executive with extensive experience leading transformative change in Medicaid and healthcare services. He brings expertise in strategy, public policy, and healthcare innovation. Lynch previously served as acting deputy administrator and chief of staff at the Centers for Medicare & Medicaid Services (CMS), as well as deputy administrator and director of the Center for Medicaid & CHIP (Children's Health Insurance Program) Services during President Trump's first term in office. While at CMS, Lynch led the early Medicaid COVID-19 response, rapidly deploying new policies and processes that enabled over 500 approvals of emergency actions aimed at supporting state efforts to increase telehealth access, streamline eligibility processes, and sustain community-based long-term-care providers. Prior to his federal service, Lynch held leadership roles as Medicaid director for Nebraska, as chief of staff for the Louisiana Department of Health and Hospitals, and as senior vice president at Commonwealth Care Alliance. He currently serves as vice president and regional Medicaid president for Humana in its Texas division.

    "I am pleased to join Acentra Health's Healthcare Advisory Board and collaborate with such a distinguished group of experts," said Lynch. "The company's mission aligns with my own passion for using emerging advances in technology to improve quality of care and efficiency in healthcare operations, and I look forward to helping Acentra Health address its clients' most complex challenges."

    About Jami Snyder

    Jami Snyder is a seasoned healthcare leader with more than 20 years of experience in public health and the private healthcare industry. Her expertise spans regulatory oversight, policy development, and leadership advisory services to states, payers, and providers. Snyder was appointed by Arizona Governor Doug Ducey to serve as the state's Medicaid director, holding that position for four years, where she led transformative initiatives to improve access and quality of care, particularly during the COVID-19 pandemic. Previously, Snyder served as associate commissioner for Medicaid/CHIP (Medicaid director) in Texas. She also served as president of the board for the National Association of Medicaid Directors (NAMD) and is a commissioner for the Medicaid and CHIP Payment and Access Commission (MACPAC), a non-partisan committee that advises Congress and state governments on policy and access issues related to Medicaid and CHIP. Snyder is currently president and CEO of JSN Strategies, LLC, a healthcare consultancy firm.

    "Acentra Health has a respected reputation as a trusted partner to state and federal clients for driving meaningful change that improves healthcare outcomes and delivers program value," said Snyder. "I look forward to contributing to the company's efforts to improve the quality and efficiency of healthcare delivery for healthcare consumers across the country."

    An additional change to the board includes the appointment of current board advisor Julie Boughn as chair. A former director of the Data and Systems Group for CMS's Center for Medicaid and CHIP Services (CMCS), Boughn joined the board in 2022 following an esteemed 30-year career in the health and information technology sectors. She specializes in data analysis, strategy, and Medicaid enterprise system modernization.

    In addition to advising Acentra Health's executive leaders, healthcare advisory board members serve as a vital resource to the company's portfolio of state, federal, and commercial clients. Members participate in regularly scheduled client focus group meetings, providing strategies for improving healthcare delivery and maximizing budget dollars. Advisory board members also support the company and its clients as subject matter experts, presenting at industry events and conferences. The nine-member board comprises experts across government, healthcare, and technology, including:

    • Dr. Raquel Bono – Retired Vice Admiral, U.S., Navy and former Director, Defense Health Agency.
    • Julie Boughn – Former Director, Data and Systems Group at the Center for Medicaid and CHIP Services within CMS, and healthcare technology innovator.
    • Aneesh Chopra – Chief Strategy Officer, Arcadia, and the nation's first U.S. Chief Technology Officer under President Obama.
    • Bobbie Greene Kilberg – Former President and CEO, Northern Virginia Technology Council, and technology policy expert.
    • Dr. Elder Granger – Retired Major General, U.S. Army, former Deputy Director/Program Executive Officer, TRICARE Management Activity, and President and CEO, THE 5Ps LLC, focusing on healthcare leadership.
    • Ryan Howells – Principal at Leavitt Partners and leading expert in healthcare data interoperability at the CARIN Alliance.
    • Charlies Milligan – CEO at Health Management Associates and former Medicaid Director for Maryland and New Mexico, with extensive policy and programmatic expertise.

    Read their bios and learn more acentra.com.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused service models for care management, clinical assessments, and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com.

    Media Contact:

    Janice Moore

    Vice President, Corporate Communications

    703-214-3552

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/218de5be-f33a-48e4-92da-7b696ac3bea8

    https://www.globenewswire.com/NewsRoom/AttachmentNg/60097542-70e4-4621-a0fb-b76671d2027e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/7c0f41f0-1e82-41b1-9565-8f06173c152e



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    8/6/2024$46.00 → $44.00Overweight → Neutral
    JP Morgan
    1/19/2024$40.00 → $41.00Buy → Neutral
    Citigroup
    More analyst ratings

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acentra Health Named one of the 'Fastest Growing Companies' by the Washington Business Journal

    MCLEAN, Va., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to helping government and commercial healthcare clients and the populations they serve, has been named to the Washington Business Journal's Fastest Growing Companies list, which highlights private companies in the Washington, D.C., metropolitan area with the highest three-year sustained revenue growth rate. This marks the second consecutive year Acentra Health has been ranked among the region's fastest growing companies. In 2024, Acentra Health was listed as No. 26 out of 75 companies reviewed. Since that listing, the company has continued to experience sustaine

    9/17/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Prices $800 Million Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) priced its offering of $800 million aggregate principal amount of 5.050% senior notes due 2035. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. The offering is expected to close on September 19, 2025, subject to customary closing conditions. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC

    9/16/25 4:56:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Announces Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) today announced its intention to offer, subject to market and other conditions, senior notes. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC , J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering. The off

    9/16/25 8:52:17 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

    5/14/25 8:48:54 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group downgraded by Oppenheimer

    Oppenheimer downgraded Carlyle Group from Outperform to Perform

    3/19/25 8:14:15 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    9/19/25 4:16:41 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 8-K filed by The Carlyle Group Inc.

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    9/16/25 8:12:26 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form FWP filed by The Carlyle Group Inc.

    FWP - Carlyle Group Inc. (0001527166) (Subject)

    9/16/25 5:03:31 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Conway William E Jr gifted 2,000,000 shares, decreasing direct ownership by 7% to 26,999,644 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    9/5/25 5:05:14 PM ET
    $CG
    Investment Managers
    Finance

    Chief Operating Officer Lobue Lindsay was granted 496 shares, increasing direct ownership by 0.10% to 476,225 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    8/29/25 4:55:04 PM ET
    $CG
    Investment Managers
    Finance

    General Counsel Ferguson Jeffrey W. was granted 744 shares, increasing direct ownership by 0.10% to 753,999 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    8/29/25 4:55:10 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    New Medicaid Alliance to Tackle AI Safety and Standards Across States

    MCLEAN, Va., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better health outcomes for its clients and the populations they serve, today announced the launch of the Safe AI in Medicaid Alliance (SAMA), a collaborative initiative uniting Medicaid leaders, policy experts, and technology innovators to develop safe and responsible Medicaid-focused frameworks for artificial intelligence (AI) adoption and use. Created with input and participation from the Washington State Health Care Authority (HCA), the Arizona Health Care Cost Containment System (AHCCCS), Amazon Web Services (AWS), McKinsey & Co., Arcadia, an

    9/9/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names Marnie Keogh as Senior Vice President of Marketing

    MCLEAN, Va., July 21, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Marnie Keogh has joined the company as Senior Vice President of Marketing. In this role, Keogh will lead the company's integrated marketing strategy, driving initiatives across brand development, digital marketing, thought leadership, and go-to-market campaigns. "Marnie brings a distinguished career in healthcare marketing and communications, with a proven ability to drive brand transformation, operational excellence, and digit

    7/21/25 9:47:00 AM ET
    $CG
    Investment Managers
    Finance

    SS&C Technologies to Acquire Calastone

    SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) today announced a definitive agreement to acquire Calastone, the largest global funds network and leading provider of technology solutions to the wealth and asset management industries, from global investment firm Carlyle. The purchase price is approximately £766 million (approximately US $1.03 billion), subject to certain adjustments. Headquartered in London, Calastone operates the largest global funds network, connecting more than 4,500 of the world's leading financial organizations across 57 markets. The acquisition is expected to close in Q4 2025, subject to regulatory approvals. SS&C expects the acquisition to be accretive within 12 mont

    7/21/25 4:00:00 AM ET
    $CG
    $SSNC
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Prices $800 Million Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) priced its offering of $800 million aggregate principal amount of 5.050% senior notes due 2035. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. The offering is expected to close on September 19, 2025, subject to customary closing conditions. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC

    9/16/25 4:56:00 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Announces Senior Notes Offering

    WASHINGTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) today announced its intention to offer, subject to market and other conditions, senior notes. The notes will be fully and unconditionally guaranteed by Carlyle's indirect subsidiaries Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C. Carlyle intends to use the net proceeds from the sale of the notes for general corporate purposes. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC , J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering. The off

    9/16/25 8:52:17 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2025, Declares Third Quarter 2025 Dividend of $0.40 Per Common Share

    NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its second quarter ended June 30, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Despite market uncertainty, the second quarter was another record quarter of originations for both CGBD and the broader Carlyle Direct Lending platform. With CGBD net financial leverage at the mid-point of our target range, we remain well positioned to benefit from the expected pickup in deal volume in the second half of the year. Although spreads in the overall market remain hist

    8/5/25 4:01:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance